XBP1 and neoplasm: Indeed, we previously determined that skin immunization with cDNA encoding xbp1 and hsp70 fused to a tumor-associated antigen is therapeutic against established tumors in a CD103+DC-dependent, pDC-dependent and CD8+ T cell-dependent manner.57 58